Araviveincis A Late Clinical Stage Oncology Company Developing Transformativetargeted Therapeutics To Treat Metastatic Diseasethe Company Is Based In Houstontexasand Has A Satellite Offices In The Research Triangle Park Area In Ncand Bethesdamdfor More Informationplease Visit Our Website At Http Www Aravive Com Our Primary Therapeutic Focus Is The Gas6 Axl Pathwaywhere Axl Receptor Signaling Plays A Critical Role In Multiple Types Of Malignancies By Promoting Metastasis And Cancer Cell Survivalour Technologyoriginated In The Laboratories Of Dramato Giaccia And His Colleagues At Stanford Universityuses Genetic Screening To Identify Critical Targets For The Development Of Therapeutic Molecules For Cancer Therapy While Sparing Healthy Cellsthis Strategy Is Designed To Enable Us To Interrupt Oncogenic Signals Andusing Our High Affinity Decoy Receptorsoutcompete Cancer S Ability To Growmetastasize And Acquire Resistance To Treatments We Believe Our Unique Cancer Therapies May Hold Promise As A Monotherapy Or In Combination With Other Cancer Treatmentsaugmenting The Anti Tumor Activity Of Radiotherapychemotherapyimmuno Therapeutics And Cancer Vaccinesby Targeting Advanced Or Metastatic Diseaseour Approach Has The Potential To Significantly Improve Survival Rates While Simultaneously Reducing Toxicity In Cancer Patients
